[Vascular endothelium in the processes of hemostasis and thrombosis. The role of prostacyclin and EDRF].
Radomski
M W
MW
Zakład Farmakologii Doświadczalnej Katedry Farmakologii Akademii Medycznej w Krakowie.
D001161:Arteriosclerosis / Q000150:complications / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology*; D011464:Epoprostenol / Q000096:biosynthesis / Q000172:deficiency / Q000502:physiology* / Q000627:therapeutic use; D006801:Humans; D009569:Nitric Oxide / Q000096:biosynthesis / Q000172:deficiency / Q000502:physiology* / Q000627:therapeutic use; D010974:Platelet Aggregation / Q000187:drug effects / Q000502:physiology*; D011465:Prostaglandins, Synthetic / Q000627:therapeutic use; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*
D011465:Prostaglandins, Synthetic; D009569:Nitric Oxide; D011464:Epoprostenol
Sródbłonek naczyń krwionośnych w procesach hemostazy i zakrzepicy. Rola prostacykliny i EDRF.